Todd Taskey

Whitebox empowers brands with a modern commerce platform for omnichannel retail success. This first-of-its kind platform is powered by omnichannel data, connected to every relevant marketplace and united with a trusted fulfillment network. Proprietary technology and a curious team of experts guide brands through the entire ecommerce lifecycle, with solutions that overcome the complexities of modern commerce. Whitebox’s full-service marketplace agency optimizes the selling and advertising of goods across all relevant channels, while its fulfillment centers operate a high-volume, low-defect network for brands wherever they need to be. Powered by this access to omnichannel data from both sales and fulfillment transactions, Whitebox’s powerful platform yields access to more data and greater insights to fuel brand decisions. From Factory Floor to Front Door™, Whitebox helps brands seize every opportunity in the value chain. Learn more at whitebox.com.

Adaptive Phage Therapeutics (APT) is a clinical-stage company advancing therapies addressing multi-drug resistant infections. Prior antimicrobial therapeutic approaches have been “fixed,” while pathogens continue to evolve resistance to each of those therapeutics, causing those drug products to become rapidly less effective in commercial use as antimicrobial resistance (AMR) increases over time. APT’s PhageBank™ approach leverages an ever-expanding library of bacteriophage (phage) that collectively provide evergreen broad spectrum and polymicrobial coverage. PhageBank™ phages are matched through a proprietary phage susceptibility assay that APT has teamed with Mayo Clinic Laboratories to commercialize on a global scale. APT’s technology was originally developed by the biodefense program of U.S. Department of Defense. APT acquired the world-wide exclusive commercial rights in 2017. Under FDA emergency Investigational New Drug allowance, APT has provided investigational PhageBank™ therapy to treat more than 40 critically ill patients in which standard-of-care antibiotics had failed.

Zoomph is helping teams, leagues brands, and agencies measure the value of sponsorships & understand their audiences for sports and entertainment 📈🙌

StreetShares is a financial technology company powering community banks and credit unions with next-generation technology to serve the digital business lending needs of U.S small business owners. It features core-friendly integrations including: all-digital applications, automated scoring & decisioning, advanced portfolio analytics and data-driven sales and marketing tools for mission-driven community lenders. StreetShares, StreetShares.com, StreetShares Platform, Atlas and the StreetShares and Atlas logo are trademarks or service markets of StreetShares, Inc. These materials are not an offer to sell, or the solicitation of an offer to purchase, any securities.

RightEye delivers the world’s most advanced, commercially available eye-tracking technology platform. We provide solutions to three high value markets: (1) Health and vision care professionals use our platform to detect several hard-to-diagnose conditions objectively and accurately, including serious vision and neurological disorders. (2) Professional and college sports teams use our platform to identify the visual skills of their athletes and improve their performance. (3) Metaverse hardware manufacturers and content developers embed our platform to gain valuable insights about their users, improve the usability and performance of their products, speed adoption, and drive growth. No other eye-tracking platform is as functionally complete, data rich, and successful in the markets where eye-tracking technologies are essential.

Vector Solutions, the leading provider of software solutions for learning, operational readiness, workforce management, and risk management, provides Vector LiveSafe as the trusted and experienced mobile platform for two-way safety and security risk communications, emergency notifications, and safety tools and resources. Whether it's physical safety and security threats, lone worker risks, or workplace safety concerns, the Vector LiveSafe Platform provides all of the necessary tools to keep your organization safe, healthy, and informed. Please follow Vector Solutions to get the latest updates. For more information, visit https://www.vectorsolutions.com/solutions/vector-livesafe/

Tower Partners is a leading Private Investment Bank and Advisory Firm providing premier service to the middle market. Our team of Wall Street veterans have advised sell-side and buy-side engagements with over $15.7 billion in value for entrepreneurs, family-run businesses and financial sponsors.

Whitebox empowers brands with a modern commerce platform for omnichannel retail success. This first-of-its kind platform is powered by omnichannel data, connected to every relevant marketplace and united with a trusted fulfillment network. Proprietary technology and a curious team of experts guide brands through the entire ecommerce lifecycle, with solutions that overcome the complexities of modern commerce. Whitebox’s full-service marketplace agency optimizes the selling and advertising of goods across all relevant channels, while its fulfillment centers operate a high-volume, low-defect network for brands wherever they need to be. Powered by this access to omnichannel data from both sales and fulfillment transactions, Whitebox’s powerful platform yields access to more data and greater insights to fuel brand decisions. From Factory Floor to Front Door™, Whitebox helps brands seize every opportunity in the value chain. Learn more at whitebox.com.

Adaptive Phage Therapeutics (APT) is a clinical-stage company advancing therapies addressing multi-drug resistant infections. Prior antimicrobial therapeutic approaches have been “fixed,” while pathogens continue to evolve resistance to each of those therapeutics, causing those drug products to become rapidly less effective in commercial use as antimicrobial resistance (AMR) increases over time. APT’s PhageBank™ approach leverages an ever-expanding library of bacteriophage (phage) that collectively provide evergreen broad spectrum and polymicrobial coverage. PhageBank™ phages are matched through a proprietary phage susceptibility assay that APT has teamed with Mayo Clinic Laboratories to commercialize on a global scale. APT’s technology was originally developed by the biodefense program of U.S. Department of Defense. APT acquired the world-wide exclusive commercial rights in 2017. Under FDA emergency Investigational New Drug allowance, APT has provided investigational PhageBank™ therapy to treat more than 40 critically ill patients in which standard-of-care antibiotics had failed.

Zoomph is helping teams, leagues brands, and agencies measure the value of sponsorships & understand their audiences for sports and entertainment 📈🙌

StreetShares is a financial technology company powering community banks and credit unions with next-generation technology to serve the digital business lending needs of U.S small business owners. It features core-friendly integrations including: all-digital applications, automated scoring & decisioning, advanced portfolio analytics and data-driven sales and marketing tools for mission-driven community lenders. StreetShares, StreetShares.com, StreetShares Platform, Atlas and the StreetShares and Atlas logo are trademarks or service markets of StreetShares, Inc. These materials are not an offer to sell, or the solicitation of an offer to purchase, any securities.